Montana’s Medicaid Expansion Conundrum

HELENA, Mont. — Despite concerns about what Congress and the Trump administration might have planned for Medicaid, Montana’s Republican-led legislature and GOP governor appear ready to keep the state’s Medicaid expansion program in place beyond its scheduled end date this summer. State lawmakers don’t have the luxury of waiting until the federal picture sharpens. They…

Read More

Let’s Check the Math on Health Subsidies

By KIM BELLARD It’s December 3, and, to no one’s surprise, Congress still has not acted on extending the expanded health care premium tax credits for ACA. To Congress, the subsidies don’t expire until the end of the year, so they figure they have until at least then to act, or maybe sometime after that,…

Read More

Roche Commits to $50B in U.S. Manufacturing and R&D Investments as Pharma Tariffs Loom

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene therapy and cardiometabolic disease. The plans follow U.S. capital expenditure announcements from several big pharmaceutical companies. The post Roche Commits to $50B in U.S. Manufacturing and R&D Investments as Pharma Tariffs Loom appeared first on…

Read More

Induced Mesenchymal Stem Cells: A New Frontier in Ovarian Cancer Treatment

Ovarian cancer urgently needs bold, transformative treatment approaches – not just small, incremental improvements. Synthetic, allogeneic iMSCs as tumor-targeting delivery vehicles are an example of how cell biology and engineering may unite and overcome longstanding oncology challenges. The post Induced Mesenchymal Stem Cells: A New Frontier in Ovarian Cancer Treatment appeared first on MedCity News.

Read More